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Abstract The minimal sequence requirement of Crithidia
tubulin polyglutamylase is already fulfilled by tubulin-related
peptides carrying a free K-carboxylate on a glutamic acid
residue. Since the product of each glutamylation step fulfills the
substrate requirements necessary for the next cycle, very long
side chains are generated with brain tubulin as a substrate. Up to
70 mol of glutamic acid was incorporated per KL-heterodimer.
We speculate that the strict choice of a particular glutamate
residue for the formation of the isopeptide bond initiating a novel
side chain is made by a tubulin monoglutamylase which requires
the entire tubulin as substrate.
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1. Introduction
The acidic carboxy-terminal region of tubulins, which is not
revealed in the atomic model of the KL-dimer [1], is subject to
three unique post-translational modi¢cations, which seem to
be based on ATP-dependent formation of peptide bonds. Tu-
bulin tyrosine ligase, which has been puri¢ed and cloned from
mammalian brain, restores the C-terminal tyrosine previously
removed by a carboxypeptidase-like activity from some K-tu-
bulins [2]. Polyglutamyl and polyglycyl side chains of various
lengths can be formed at the Q-carboxylate of one or more
speci¢c glutamate residue(s) via an isopeptide bond de¢ning
the branch site [3,4]. Polyglycylation is found in many [4^6]
but not all axonemes [7,8]. Polyglutamylation, originally dis-
covered by mass spectrometry of mammalian brain tubulin
peptides [3], is a general tubulin modi¢cation, which extends
to the oldest eukaryotes [7^9] but, as shown here, seems to be
absent in yeast.
Two enriched enzyme preparations of tubulin polyglutamy-
lase are currently available. One is derived from the brain of 3
day old mice [10], the other is obtained by stripping the stable
microtubular cytoskeleton of the trypanosomatid Crithidia
fasciculata with moderate salt and by subsequent puri¢cation
steps [11]. Similarities and di¡erences of the two enzyme prep-
arations have been discussed. In addition, we noted that two
synthetic peptides with an oligoglutamyl side chain, corre-
sponding to the carboxy-terminal end of brain K- and L-tu-
bulin, are accepted by the Crithidia enzyme, albeit at a low
e⁄ciency [11]. Using a broader collection of tubulin-related
peptides, we now show that the presence of a free K-carbox-
ylate on a glutamic acid residue is necessary and su⁄cient for
peptide glutamylation catalysed by Crithidia tubulin polyglu-
tamylase. Since the product of each glutamylation reaction
ful¢lls the substrate requirement for the next cycle, a progres-
sive elongation of side chains is achieved. With brain tubulin
as a substrate, analysis of the terminal peptides identi¢ed var-
iants carrying up to 50 glutamic acid residues.
2. Materials and methods
C. fasciculata culture, the puri¢cation of tubulin polyglutamylase
from the 0.25 M salt extract of isolated cytoskeletons and the gluta-
mylation assays were as described [11]. Synthetic peptides were incu-
bated at 0.1 mM with partially puri¢ed enzyme (fraction II after ATP
a⁄nity chromatography), 4 mM glutamic acid and 2 mM ATP in the
standard assay.
Glutamylation products were analysed by reverse-phase high per-
formance liquid chromatography (HPLC), mass spectrometry and au-
tomated Edman degradation as described [11]. Alternatively, a 10 Wl
aliquot of the reaction mixture was diluted to 400 Wl with 20 mM Tris-
HCl, pH 8 (bu¡er A), and subjected to anion exchange chromatog-
raphy on a TSKgel DEAE-NPR column (Tosohaas, Stuttgart, Ger-
many). The column dimensions were 4.6U35 mm. Peptides were
eluted with a 2.7 ml linear gradient of 0^0.5 M NaCl in bu¡er A
followed by a 0.9 M salt wash. The £ow rate was 200 Wl/min and
100 Wl fractions were collected. Peptides present in the DEAE frac-
tions were processed for mass spectrometry using C18-ZipTips (Milli-
pore, Bedford, MA, USA) according to the instructions of the man-
ufacturer.
Puri¢ed tubulin from Saccharomyces cerevisiae was purchased from
Cytoskeleton (Denver, CO, USA). An additional preparation was
kindly provided by Dr. E. Schiebel (Glasgow, UK). Yeast tubulin
was glutamylated at 0.1 mg/ml, pig brain tubulin at 0.3 mg/ml, with
4 mM [3H]Glu and 0.1 Wg of a partially puri¢ed polyglutamylase
fraction obtained after ATP a⁄nity chromatography. Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was per-
formed in the presence of 6 M urea to separate K- and L-tubulins.
Immunoblots were analysed with monoclonal antibodies YL1/2, spe-
ci¢c for tyrosinated K-tubulin [12], the L-tubulin-speci¢c antibody
KMX-1 [13] and the glutamylation-speci¢c antibody GT335 [14].
3H-autoradiography was performed using BioMax TranScreen LE
(Kodak, Rochester, NY, USA).
3. Results
3.1. Polyglutamylation of synthetic tubulin peptides
We previously found [11] that synthetic peptides corre-
sponding to the carboxy-terminal 19 and 15 residues of L-
and K-brain tubulin are substrates of Crithidia tubulin poly-
glutamylase, provided that they carried an oligoglutamyl side
chain of four residues on the glutamate at position 9, i.e. the
established glutamylation sites Glu-445 for K1/K2-isoforms
and Glu-435 for class II L-tubulin [3,15,16]. We now used a
set of di¡erent synthetic peptides to characterise the sequence
requirements for peptide glutamylation in detail. Fig. 1A sum-
marises the results of the peptide assays.
Reduction of the length of the side chain to the monoglu-
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tamylated derivatives had no in£uence on the glutamylation
reaction. Up to ¢ve and six additional glutamates were incor-
porated into the branched K- (Fig. 1C) and L-peptide (Fig.
1B). Automated Edman degradation and carboxypeptidase A
treatment con¢rmed that the additional glutamyl residues
were added to the existing side chain of the substrate. Next,
we tested a series of peptides in which the monoglutamyl side
chain was attached to di¡erent glutamate residues of the main
chain. Shifts in K were by plus or minus two residues while for
L, shifts of minus two and plus nine residues were tried. These
derivatives were all accepted as substrates (Fig. 1A,D). All
peptides recognised so far as substrates have a single gluta-
mate with a free K-carboxylate group, provided by the side
chain branch, since the carboxy-terminal residue is either a
tyrosine (K) or an alanine (L). We therefore tested a series
of carboxy-terminally truncated K- and L-peptides without a
side chain. All peptides ending with glutamate were recog-
nised as substrates and automated sequencing con¢rmed
that the extra glutamyl residues incorporated (Fig. 1A) were
added to the carboxy-terminal end. For instance, the peptides
corresponding to detyrosinated K-tubulin or to K-tubulin
lacking an additional glutamate (v2 tubulin) increased by up
to three glutamyl residues. Judged by the maximal number of
glutamyl units added and by the relative peak heights ob-
served in mass spectrometry, the elongation at the carboxy-
terminal end was somewhat less e⁄cient than the elongation
of the side chains in the other peptides. In contrast, peptides
ending with glycine or aspartic acid as well as the full length
peptides ending with tyrosine or alanine were not accepted by
the enzyme (Fig. 1A).
Anion exchange chromatography on a DEAE column pro-
vided an additional and convenient assay of the glutamylation
reaction (Fig. 2). Peptides were resolved according to the
length of their side chains and the absorption pro¢le directly
visualised the glutamylation process. However, the least abun-
dant species detected by mass spectrometry (Fig. 1A,C) were
not visible in the absorption pro¢le (Fig. 2). Even after 20 h,
the original monoglutamylated substrate peptides were still
the major components in the reaction mixture, indicating
the rather low e⁄ciency of peptide glutamylation.
Fig. 1. Substrate-speci¢city of Crithidia tubulin polyglutamylase in a peptide system. A: Summary of the results with the peptide assays. Bold
letters in the sequences indicate the positions of the oligoglutamyl side chains. The number in brackets past the sequence gives the length of
the glutamyl side chain of the substrate. Substrate activity is given in the penultimate column. The last column (vE) gives the number of glu-
tamyl residues incorporated. B: Mass spectrum of the reaction product obtained with the normal monoglutamylated L-peptide. The sequence
of the substrate is given at the top. A star marks the corresponding peak in the mass spectrum. The additional peaks are numbered according
to the length of the glutamyl side chain. Up to ¢ve additional glutamyl residues are incorporated. C: Mass spectrum of the reaction product
obtained with the normal monoglutamylated K-peptide showing the incorporation of up to six additional glutamyl residues. D: Elongation of a
monoglutamylated K-peptide with the side chain shifted by two positions (see sequence at the top). Up to six additional residues are incorpo-
rated.
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3.2. Hyperglutamylation of brain tubulin
We also analysed the glutamylation of mammalian brain
tubulin by tubulin polyglutamylase [11] in more detail. Radio-
active glutamic acid was incorporated up to levels of 70 mol
per mol KL-tubulin heterodimer (Fig. 3A). Analysis of ali-
quots of the reaction taken at 0 and 16 h showed in SDS-
PAGE a striking reduction of the electrophoretic mobility of
both K- and L-tubulin upon polyglutamylation. The stained
tubulin bands were electro-eluted from the gel, digested with
endoproteinase Lys-C (K-tubulin) and CNBr (L-tubulin), re-
spectively, and the acidic carboxy-terminal peptides were pu-
ri¢ed by anion exchange chromatography and reverse-phase
HPLC [7^9]. Mass spectrometric analysis of the various
HPLC fractions revealed extensive polyglutamylation. Up to
31 additional glutamyl residues were found for the K-peptides.
Fig. 3C shows a mass spectrum for a fraction containing
detyrosinated K-peptides with 8^27 extra glutamyl residues.
Automated sequencing revealed only one side chain situated
as expected at Glu-445. The highly glutamylated K-peptides
were found in the tyrosinated and detyrosinated form and in a
subset additionally modi¢ed by phosphorylation at Ser-439 as
noted previously for a synthetic K-peptide [11]. While the
most abundant variants carried 15^17 extra glutamyl residues,
we also observed a minor fraction of the unmodi¢ed peptide
and of peptides with shorter side chains. In contrast, tubulin
puri¢ed from brain usually contains up to four or six extra
glutamyl residues per K- and L-tubulin [3,15,16]. We also ob-
served the peptides from the K4-isoform with up to 32 glu-
tamyl residues. Currently, we do not know how they distrib-
ute over the two side chains located at glutamic acid residues
443 and 445 [11,17].
In a di¡erent experiment, the carboxy-terminal peptides
were directly generated from the glutamylation reaction with-
out the preparative SDS-PAGE step. Under these conditions,
even higher glutamylation levels were recorded by mass spec-
trometry. Both K- and L-peptides contained up to 50 extra
glutamyl residues with the average number centring around
35 (data not shown). This value is in good agreement with the
molar level calculated from the radioactive glutamate incor-
poration (Fig. 3A).
Fig. 2. Glutamylation of synthetic peptides by Crithidia polygluta-
mylase, monitored by anion exchange chromatography on a DEAE
column. Aliquots of the reaction with the monoglutamylated K-pep-
tide (K1E, upper panel) and the normal monoglutamylated L-peptide
(L1E, lower panel) were taken at the indicated times. The reaction
was followed by absorption at 214 nm. Peaks are numbered accord-
ing to the length of the glutamyl side chain obtained by mass spec-
trometry. For peptide sequences, see Fig. 1A.
Fig. 3. Extensive glutamylation of mammalian brain tubulin catalysed by Crithidia tubulin polyglutamylase. A: Time-course of tubulin glutamy-
lation followed by incorporation of radioactive glutamic acid and expressed as the number of glutamyl residues added per tubulin dimer. B:
SDS-PAGE of regular and highly glutamylated brain tubulin, obtained by a 16 h treatment with the Crithidia enzyme. Note the lower mobility
of the K- and L-tubulin bands. C: Mass spectrum of the C-terminal peptides of glutamylated K-tubulin, obtained by digestion with endoprotei-
nase Lys-C. The result of automated sequence analysis of the corresponding fraction is given at the top. The variants have side chain lengths
between eight and 27 glutamyl residues. They are derived from detyrosinated K-tubulin and also show complete phosphorylation of the single
serine residue. The X in the sequence marks the position of the glutamyl side chain, i.e. Glu-445.
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3.3. Immunological evidence for a monoglutamylation activity
Since none of the synthetic peptides can be used to monitor
the formation of the isopeptide bond involved in the synthesis
of the ¢rst glutamyl side chain residue, we searched for a
di¡erent detection system. Fig. 4 gives the results of SDS-
PAGE and immunoblots on puri¢ed yeast tubulin. The barely
resolved K- and L-tubulins are recognised by the monoclonal
antibodies YL1/2 and KMX-1, which are speci¢c for K- and
L-tubulin, respectively. In contrast, no reaction was observed
with the antibody GT335, which recognises a motif already
provided by monoglutamylation of K-tubulin [14]. This situa-
tion changed when yeast tubulin previously treated with par-
tially puri¢ed polyglutamylase was used. GT335 now detected
the K-tubulin band (Fig. 4, lane 6) while a control blot of the
enzyme processed without yeast tubulin through the standard
assay was negative with GT335 (Fig. 4, lane 7). A parallel
blot and autoradiograph on yeast tubulin treated with
[3H]glutamate and enzyme con¢rmed that the gain of
GT335 reactivity was due to the incorporation of glutamic
acid into K-tubulin (Fig. 4, lane 8). The combined results
indicate that puri¢ed yeast tubulin is not glutamylated and
that an enzyme activity present in our preparation can intro-
duce the ¢rst glutamic acid of a side chain via isopeptide bond
formation.
4. Discussion
We used a set of synthetic peptides related to the carboxy-
terminal end of brain K- and L-tubulin to characterise the
substrate-speci¢city of a partially puri¢ed preparation of tu-
bulin polyglutamylase from the trypanosomatid C. fasciculata
[11]. The combined results (Fig. 1A) show that peptides were
subject to polyglutamylation if they displayed a free K-carbox-
ylate group of a glutamic acid residue. This minimal sequence
requirement was already ful¢lled by a series of monoglutamy-
lated peptides carrying a single glutamate connected by an
isopeptide bond to a glutamate of the main peptide chain
and by those unbranched peptides ending with a carboxy-ter-
minal glutamate residue. In the peptide system, extension of
an already existing side chain was favoured over the extension
past a carboxy-terminal glutamate. The speci¢city for a free
K-carboxylate provided by a glutamic acid residue was abso-
lute, internal glutamic acid residues were not modi¢ed and
terminal residues other than glutamic acid were not recog-
nised. Within this peptide system, no isopeptide bond forma-
tion (‘branching’) was observed. The length and relative posi-
tion of an existing side chain had no obvious in£uence on the
elongation. Thus, the polyglutamylase has a low sequence
requirement and its activity is triggered once it encounters a
monoglutamylated K- or L-tubulin. This low sequence require-
ment can explain the generation of very long side chains when
brain tubulin is used as a substrate (Fig. 3). The product of
each glutamylation step again ful¢lls the sequence require-
ments necessary for the next cycle. Thus, glutamyl residues
are added sequentially onto tubulin, resulting in progressive
elongation of the oligoglutamyl side chain (see below).
Brain tubulin is by far a much better substrate of tubulin
polyglutamylase than the various synthetic peptides. As ar-
gued before for tubulin tyrosine ligase [18], the peptides
may not make optimal contacts with the modifying enzyme
or may be less able to adopt the correct conformation for
optimal polyglutamylation. Treatment of puri¢ed brain tubu-
lin results in a hyperglutamylated preparation containing up
to 50 extra glutamyl residues per K- and L-tubulin. These
values exceed the highest values reported for in vivo glutamy-
lated tubulins, which range from 15 for Trypanosoma brucei
[7] and 17 for the basal apparatus of a green alga [19] to 22
for Crithidia K-tubulin (our unpublished results). Indeed, the
high e¡ectiveness of hyperglutamylation, so far only observed
in vitro, invites the possible need for an opposing enzymatic
activity acting as a deglutamylase. Some evidence for such an
activity has also emerged from in vivo studies [20]. On the
other hand, our results on di¡erent methods to isolate the
carboxy-terminal peptides of enzymatically glutamylated
brain tubulin open the possibility that the most extensively
glutamylated species can be lost in some procedures [7^
9,19]. Highly glutamylated tubulin species migrate aberrantly
in SDS-PAGE (Fig. 3B and Fig. 9 in reference [10]) and their
carboxy-terminal peptides may be recovered in a lower yield
by in gel digestion and moved from the bulk part in ion
exchange chromatography. Thus, previously reported values
[7^9,19] may be an underestimate of in vivo polyglutamyla-
tion.
The low sequence requirement of the Crithidia polygluta-
mylase in the peptide assay contrasts the high site selectivity
observed in various K- and L-tubulins. In most cases, only a
particular glutamic acid residue in a short sequence, rich in
glutamic acids, carries the branched side chain [3,7,15,16].
Thus, it seems that the site-speci¢city, which necessarily in-
volves an isopeptide bond, is established by a monoglutamy-
lase, which initiates the correct side chain due to complex
formation with tubulin. Such a monoglutamylase together
with polyglutamylase activity was observed in a partially pu-
ri¢ed enzyme preparation from 3 day old mice [10]. Using
yeast tubulin, which seems to be unglutamylated, as a sub-
strate and the monoclonal antibody GT335 as a detection
system, we found a convenient assay for monoglutamylation
activity (Fig. 4). This immunological assay can serve in the
future for puri¢cation of the monoglutamylase.
Fig. 4. Immunological evidence for a monoglutamylase activity.
Yeast tubulin was separated by SDS-PAGE (lane 2, marker proteins
in lane 1, molecular weights given in kDa) and K- and L-bands are
stained in immunoblots (lanes 3 and 4) by monoclonal antibodies
YL1/2 (K) and KMX-1 (L). The glutamylation-speci¢c antibody
GT335 does not recognise yeast tubulin (lane 5) unless it is treated
with a partially puri¢ed glutamylase fraction from Crithidia (lane 6).
Control blot of enzyme processed without yeast tubulin through the
standard assay (lane 7). A parallel [3H]Glu autoradiography demon-
strates the incorporation of glutamic acid into yeast K-tubulin
(lane 8).
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